Pharmaceutical Strategies Group (“PSG”), an EPIC company, published its 2025 Trends in Drug Benefit Design Report, delivering critical insights into how payers are navigating a rapidly ...

“What drives us is the idea that we can design a single drug to treat obesity and simultaneously mitigate the risk of developing a long list of health problems plaguing society,” says Krishna Kuma ...

For decades, direct-to-consumer (DTC) pharmaceutical ads have been a staple of American television—softly lit scenes, ...

What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...

This summer be sure to stop by the Yankton Community Library at 515 Walnut Street and “Color Your World!” Don’t forget to bring your art brochure to library events! Collect ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery ... which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced ...

They could support better antibody drugs, targeted cancer treatments or diagnostic tools. This research highlights the growing influence of deep learning in protein design. By expanding the accessible ...

June 14, 2025 • Health Secretary Robert F. Kennedy Jr. apparently embraces the outdated "miasma theory" of disease instead of the widely accept "germ theory" of disease, which may help explain ...

Department of Chemistry and Chemical Biology, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, New Jersey 07030, United States ...